PMV Pharmaceuticals Inc

NASDAQ:PMVP  
22.38
+0.53 (+2.43%)
Earnings Announcements

PMV Pharmaceuticals Reports Third Quarter 2021 Financial Results

Published: 11/12/2021 12:47 GMT
PMV Pharmaceuticals Inc (PMVP) - Pmv Pharmaceuticals Reports Third Quarter 2021 Financial Results and Corporate Highlights.
Qtrly Net Loss per Share $0.33.
Q3 Earnings per Share View $-0.30 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.34

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.37

More details on our Analysts Page.